S&P 500   4,567.80 (+0.38%)
DOW   35,950.89 (+1.47%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.27 (+1.25%)
BABA   74.88 (+0.28%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.26 (-3.12%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.07%)
GE   121.80 (+2.47%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.25%)
PFE   30.47 (+1.30%)
PYPL   57.61 (-0.62%)
XOM   102.74 (+0.39%)
S&P 500   4,567.80 (+0.38%)
DOW   35,950.89 (+1.47%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.27 (+1.25%)
BABA   74.88 (+0.28%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.26 (-3.12%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.07%)
GE   121.80 (+2.47%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.25%)
PFE   30.47 (+1.30%)
PYPL   57.61 (-0.62%)
XOM   102.74 (+0.39%)
S&P 500   4,567.80 (+0.38%)
DOW   35,950.89 (+1.47%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.27 (+1.25%)
BABA   74.88 (+0.28%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.26 (-3.12%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.07%)
GE   121.80 (+2.47%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.25%)
PFE   30.47 (+1.30%)
PYPL   57.61 (-0.62%)
XOM   102.74 (+0.39%)
S&P 500   4,567.80 (+0.38%)
DOW   35,950.89 (+1.47%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.27 (+1.25%)
BABA   74.88 (+0.28%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.26 (-3.12%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.07%)
GE   121.80 (+2.47%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.25%)
PFE   30.47 (+1.30%)
PYPL   57.61 (-0.62%)
XOM   102.74 (+0.39%)

Pediatrix Medical Group Stock Price, News & Analysis (NYSE:MD)

$8.38
-0.28 (-3.23%)
(As of 05:12 PM ET)
Compare
Today's Range
$8.22
$8.67
50-Day Range
$8.64
$12.98
52-Week Range
$8.22
$17.30
Volume
625,862 shs
Average Volume
589,892 shs
Market Capitalization
$704.09 million
P/E Ratio
7.42
Dividend Yield
N/A
Price Target
$16.75

Pediatrix Medical Group MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
82.6% Upside
$15.30 Price Target
Short Interest
Healthy
3.32% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.00mentions of Pediatrix Medical Group in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
5.00%
From $1.20 to $1.26 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.83 out of 5 stars

Medical Sector

46th out of 949 stocks

Hospitals Industry

2nd out of 3 stocks


MD stock logo

About Pediatrix Medical Group Stock (NYSE:MD)

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

MD Stock Price History

MD Stock News Headlines

The Only Practical Solution to the World’s Looming Energy Crisis
There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!
Pediatrix Medical Group Inc MD
The Only Practical Solution to the World’s Looming Energy Crisis
There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!
Pediatrix Medical Group: Q2 Earnings Snapshot
How to Successfully Dream Feed Your Baby
MD vs. PGNY: Which Stock Is the Better Value Option?
Pediatrix Medical Group (NYSE: MD)
See More Headlines
Receive MD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pediatrix Medical Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/02/2023
Today
11/30/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/16/2024

Industry, Sector and Symbol

Industry
Hospitals
Sub-Industry
Health Care Services
Sector
Medical
CUSIP
58502B10
Employees
5,250
Year Founded
1979

Price Target and Rating

Average Stock Price Target
$15.30
High Stock Price Target
$23.00
Low Stock Price Target
$9.50
Potential Upside/Downside
+95.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
3 Analysts

Profitability

Net Income
$66.33 million
Pretax Margin
5.88%

Debt

Sales & Book Value

Annual Sales
$1.97 billion
Cash Flow
$1.98 per share
Book Value
$11.52 per share

Miscellaneous

Free Float
82,344,000
Market Cap
$718.37 million
Optionable
Optionable
Beta
1.73

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Dr. James D. Swift M.D. (Age 61)
    CEO & Director
    Comp: $549.53k
  • Mr. C. Marc Richards (Age 52)
    Executive VP & CFO
    Comp: $509.58k
  • Ms. Mary Ann E. Moore (Age 63)
    Executive VP, General Counsel & Secretary
    Comp: $542.02k
  • Dr. Curtis B. Pickert M.D. (Age 65)
    Executive VP & COO
  • Mr. John C. PepiaMr. John C. Pepia (Age 60)
    Senior VP & Chief Accounting Officer
    Comp: $931.2k
  • Ms. Cheryl M. VanPatten
    Senior VP & Chief Information Officer
  • Mr. Daniel Patrick Corcoran
    Senior Vice President of Administration & Managed Care
  • Mr. Charles W. Lynch C.F.A.
    Senior VP of Finance, Strategy & Investor Relations
  • Ms. Meghan K. Lublin
    Senior VP, Chief Brand & Communications Officer
  • Mr. Lee A. Wood (Age 55)
    Executive Vice President of National & Market Operations














MD Stock Analysis - Frequently Asked Questions

Should I buy or sell Pediatrix Medical Group stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pediatrix Medical Group in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" MD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MD, but not buy additional shares or sell existing shares.
View MD analyst ratings
or view top-rated stocks.

What is Pediatrix Medical Group's stock price target for 2024?

3 Wall Street analysts have issued 12-month price objectives for Pediatrix Medical Group's shares. Their MD share price targets range from $9.50 to $23.00. On average, they anticipate the company's share price to reach $15.30 in the next year. This suggests a possible upside of 82.6% from the stock's current price.
View analysts price targets for MD
or view top-rated stocks among Wall Street analysts.

How have MD shares performed in 2023?

Pediatrix Medical Group's stock was trading at $14.86 at the beginning of the year. Since then, MD shares have decreased by 43.6% and is now trading at $8.38.
View the best growth stocks for 2023 here
.

Are investors shorting Pediatrix Medical Group?

Pediatrix Medical Group saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 2,730,000 shares, a drop of 16.5% from the October 31st total of 3,270,000 shares. Based on an average daily volume of 560,900 shares, the short-interest ratio is presently 4.9 days. Currently, 3.3% of the company's stock are sold short.
View Pediatrix Medical Group's Short Interest
.

When is Pediatrix Medical Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, February 16th 2024.
View our MD earnings forecast
.

How were Pediatrix Medical Group's earnings last quarter?

Pediatrix Medical Group, Inc. (NYSE:MD) released its earnings results on Thursday, November, 2nd. The company reported $0.29 earnings per share for the quarter, missing analysts' consensus estimates of $0.40 by $0.11. The business had revenue of $506.60 million for the quarter, compared to the consensus estimate of $507.59 million. Pediatrix Medical Group had a net margin of 4.65% and a trailing twelve-month return on equity of 11.70%. Pediatrix Medical Group's revenue for the quarter was up 3.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.37 EPS.

What is Mark S. Ordan's approval rating as Pediatrix Medical Group's CEO?

6 employees have rated Pediatrix Medical Group Chief Executive Officer Mark S. Ordan on Glassdoor.com. Mark S. Ordan has an approval rating of 34% among the company's employees. This puts Mark S. Ordan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Pediatrix Medical Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pediatrix Medical Group investors own include NVIDIA (NVDA), AbbVie (ABBV), QUALCOMM (QCOM), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), Walt Disney (DIS), Wells Fargo & Company (WFC), Exxon Mobil (XOM) and Advanced Micro Devices (AMD).

Who are Pediatrix Medical Group's major shareholders?

Pediatrix Medical Group's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Earnest Partners LLC (6.07%), Charles Schwab Investment Management Inc. (1.77%), River Road Asset Management LLC (1.15%), Bank of New York Mellon Corp (0.91%), Invesco Ltd. (0.84%) and AQR Capital Management LLC (0.67%). Insiders that own company stock include James D Swift, John C Pepia, Mark S Ordan, Roger Mack Hinson, Roger Md Medel and Shirley A Weis.
View institutional ownership trends
.

How do I buy shares of Pediatrix Medical Group?

Shares of MD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:MD) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -